Zimbabwe is intensifying efforts to improve the prevention, early detection and treatment of breast and cervical cancers by integrating cancer and chronic disease services into primary health care.

PMEA returned on 19 November to the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

Global Prostate Cancer Diagnostics Market OverviewThe global prostate cancer diagnostics market is projected to grow at a CAGR of approximately 12% during the forecast period, driven by a combination ...

Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...

On 13 November 2025, Merck Sharp & Dohme LLC initiated a study is to learn if people who receive patritumab deruxtecan (also ...

Adam Brufsky, MD, PhD, addresses how the COVID-19 pandemic affected breast cancer screening rates across Pittsburgh.

According to Nova One Advisor, the global antibody drug conjugates market size is calculated at USD 16.14 billion in 2025 and ...

– Breast surgery seems to help control cancer in the breast. It could also improve life expectancy for some women.

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.